Deposit $100 to get a $100 trading bonus. Use the promo code AMANAWEB.
Deposit $200 to get a $100 trading bonus.
Use the promo code AMANAWEB.

+0.81%
Today
+0.81%
1D
Sun
Closed
Mon
3:00 AM ~ 12:00 PM
Tue
12:00 AM ~ 12:00 PM
Wed
12:00 AM ~ 12:00 PM
Thu
12:00 AM ~ 12:00 PM
Fri
12:00 AM ~ 12:00 PM
Sat
Closed
Name
Adaptive Biotechnologies Corp Leveraged
Currency
USD
Standard Leverage
1X
Enhanced Leverage
3X
Overnight Fees Buy
-0.0183%
Overnight Fees Sell
0.0016%
Market Cap
4.02B
Avg Daily Volume
2.92M
52 Week High
26.155 USD
52 Week Low
11.92 USD
Trading Hours
See hours
| Daily Overnight Fee % | Daily Overnight Fee $ | |
|---|---|---|
| BUYS | -0.01830% | $(0.183) |
| SELLS | 0.00160% | $0.016 |
*Results displayed are estimates. Actual fees may differ from those shown as market conditions change.
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunosequencing platform which combines a suite of proprietary chemistry, computational biology, and machine learning to generate clinical immunomics data to decode the adaptive immune system. It provides clonoSEQ diagnostic test which detects and monitors the remaining number of cancer cells that are present in a patient's body during and after treatment, known as Minimal Residual Disease (MRD). The company offers products and services for life sciences research, clinical diagnostics, and drug discovery applications. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was incorporated in 2009 and is headquartered in Seattle, Washington.
AdaptiveBio
+0.81%
Adaptogenics Health Corp. Announces Change of Directors
tradingview.com
6d ago

AdaptiveBio
+0.81%
Adaptive Biotechnologies Corp Q2 2026: Revenue $71.6M, EPS $(0.25) — 10-Q Summary
tradingview.com
1w ago

AdaptiveBio
+0.81%
Adaptive Biotechnologies Corporation Stock 12‑Month Price Target Raised to $23.86, Implies 6% Upside
tradingview.com
2w ago

Show more
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.